Seventh Sense lands $16M for non-invasive blood collection

Blood sampling devices maker Seventh Sense Biosystems secures $16 million in Series B funding from Siemens, Novartis, others.

Massachusetts-based Seventh Sense Biosystems added 3 new investors this month with the closing of its Series B financing round, which brought in $16 million for the the company's blood sampling devices.

Seventh Sense Biosystems Inc.

News Well, Blood Management, Funding Roundup

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1nPpdpd